FDA Inspection 1028502 — Carter BloodCare
The FDA completed an inspection of Carter BloodCare on Oct 5, 2017 in Mansfield, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 5, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mansfield, TX (United States)